Africa’s Enzyme
Manufacturing
Revolution

Fluorobiotech is building Africa’s biotech independence by unlocking local,

cost-effective production of high-value enzymes 

about
FluoroBiotech

Born from the urgent need to solve recombinant protein supply challenges in developing countries, Fluorobiotech pioneer’s local enzyme production solutions like our patented SelfPrep technology.

Biomanufacturing, Reinvented

Our patented SelfPrep technology powers scalable, affordable, and high-yield enzyme manufacturing — supporting vaccine developers, researchers, and biopharma innovators across the continent and beyond

Increased Extraction Rates

SelfPrep technology is a fundamental simplification in enzyme manufacturing that boosts enzyme extraction efficiency for higher yields

Lower Production Costs

Streamlined enzyme manufacturing reduces complexity and significantly cuts production costs

Resource Efficient

Minimizes dependence on complex equipment and harsh chemicals — enabling sustainable manufacturing

Reduced Lead Times

Our resource-efficient process enables regional manufacturing — cutting delivery times and improving supply reliability

PRODUCTS & SERVICES

For In Vitro Transcription (IVT) workflows, mRNA vaccine manufacturing, diagnostics, and research

Tailored enzyme production solutions using our proprietary technology for more affordable and consistent supply

For large-scale manufacturers seeking cost and process efficiencies

why
FLUOROBIOTECH

Affordable prices

High-performance enzymes at regionally accessible prices — supporting affordability without compromise

Patended Technology

Proprietary SelfPrep system enables efficient, scalable enzyme production — tailored for regional bioeconomies

Good support

Access expert scientific guidance from our responsive and experienced team

Convenient location

Strategically based in one of South Africa’s leading biotech hubs — driving local innovation with global relevance

Our
feedback

Frame-131
During the pandemic, we lead the world in the discovery of variants and clinical trials but we were in the back of the queue to access diagnostics, therapeutics and vaccines. That is one of the reasons why we are investing in Fluorobiotech in the production of biotechnology products that save lives and advance livelihoods.
Prof Tulio de Oliveira
Director CERI & TIME 100 Most Influencial
Anita
It is crucial that universities participate in ecosystem conversations to advocate for increased infrastructure and investment flow into science-based ventures with high commercial and global impact potential. I trust that Fluorobiotech will become a global force in enzyme manufacturing.
Dr Anita Nel
Director of Innovation & Commercialization Stellenbosch University
RichardGordon
I first got to know about Fluorobiotech when the SAMRC invested in them with interns. Since them, I have been working in partnership the Mastercard Foundation to help them to develop further to generate high level employment in Africa.
Dr Richard Gordon
SAMRC Executive Director & Chemist, Cambridge
AmadoulSall
I am the CEO of one of the largest vaccine and diagnostic manufacturing in Africa. I am working with Fluorobiotech so enzymes for vaccines, diagnostics and therapeutics for Africa can be produced in Africa.
Prof Amadou Sall
CEO Institut Pasteur de Dakar

The News Posts​

Contact Fluorobiotech

Fluorobiotech is based in the LaunchLab CERI BIO laboratories in Stellenbosch, South Africa